Navigation Links
FDA Approves First Pacemaker Deemed Safe During MRIs
Date:2/8/2011

TUESDAY, Feb. 8 (HealthDay News) --The U.S. Food and Drug Administration on Tuesday approved the first heart pacemaker designed to be safe during some MRI scans.

Pacemakers are medical devices implanted in the body to treat irregular or stalled heart beats. Until now, patients with pacemakers who needed an MRI were out of luck, since the magnetic and radiofrequency fields used by the MRI could disturb the pacemakers' settings or cause wires to overheat, accidentally shocking the heart, burning tissue, causing electrical failure and other problems.

The new pacemaker -- known as the Revo MRI SureScan Pacing System -- includes a function that is activated before a scan to prepare patients for the MRI, according to an FDA news release. Its use in MRI scans, however, is limited to certain patients, particular parts of the body and certain scanning parameters. The FDA will require training for cardiologists and radiologists who use the system.

"FDA's approval of the Revo pacemaker represents an important step forward toward greater device innovation," Dr. Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health, said in the news release. "Those patients who meet the parameters for the device will be able to maintain their critical cardiac therapy while benefiting from the precise diagnostic capability of an MRI."

"Patients with devices are restricted from having magnetic resonance imaging [MRI] exams," noted Dr. Larry A Chinitz, director of cardiac electrophysiology and the Heart Rhythm Center at NYU Langone Medical Center in New York City. "Sometimes it is a nuisance, sometimes it can be life-threatening. This new pacemaker will begin to attack the problem that these patients face. NYU Langone Medical Center will be the first in New York to implant this new device."

Almost half of those who have a pacemaker may need an MRI at some point, according to the FDA.

Before approving the new pacemaker, the FDA reviewed results from a clinical trial of 484 patients. Of those, 464 had the device implanted and then were chosen at random to receive or not receive an MRI. Of the 211 who underwent an MRI, none experienced an MRI-related complication.

The results confirmed earlier data from animal studies, computer simulation programs and other nonclinical research.

Revo is manufactured by Medtronic Inc., of Mounds View, Minn.

More information

For more on pacemakers, go to the National Library of Medicine.

--HealthDay editors

SOURCE: Larry A Chinitz, M.D., director, cardiac electrophysiology and the Heart Rhythm Center, NYU Langone Medical Center, New York City; U.S. Food and Drug Administration, news release, Feb. 8, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. FDA Approves First Drug to Prevent Premature Births
2. Swiss agency approves clinical trial of UCI-created neural stem cell therapy
3. ACGME board approves final duty hour and supervision standards for resident education
4. FDA Approves 1st Oral Drug to Reduce MS Relapses
5. FDA approves Merz Pharmaceuticals Xeomin (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm
6. Early detection of cancer: The FDA approves procedure discovered by EPFL researchers
7. FDA approves first human neural stem cell clinical trial to treat brain tumors
8. FDA Approves Stemedica IND for Ischemic Stroke Clinical Trial
9. New York State Office of Mental Health Approves New High Performance Polycarbonate Sheet for Use in All Facilities
10. House of Representatives Approves Health-Care Reform Bill
11. Congress Approves Bill Curbing Internet Tobacco Sales in Victory for Kids and Taxpayers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Approves First Pacemaker Deemed Safe During MRIs
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/26/2016)... Viejo, California (PRWEB) , ... June 26, 2016 , ... ... Final Cut Pro X. , "Film editors can give their videos a whole new ... said Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- Story Highlights: , ... health care industry is causing providers to review operating ... offers a suite of solutions for health care providers ... optimization: labor resource analysis, revenue cycle optimization and physician ... and better economics ...
(Date:6/24/2016)... -- Dublin ... the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global market ... its applications in various applications. The report deals with ... main industries: pharmaceutical and biotechnology, food and beverage, and ...
(Date:6/24/2016)... Research and Markets has announced the ... Tests" report to their offering. ... The World Market for Companion Diagnostics covers the ... analysis in the report includes the following: ... Kits) by Region (N. America, EU, ROW), 2015-2020 , ...
Breaking Medicine Technology: